24.05.2022 | Research Letter
Impact of comorbidities on the prognosis of pediatric vasovagal syncope
verfasst von:
Ya-Ru Wang, Xue-Ying Li, Jun-Bao Du, Yan Sun, Wen-Rui Xu, Yu-Li Wang, Ying Liao, Hong-Fang Jin
Erschienen in:
World Journal of Pediatrics
|
Ausgabe 9/2022
Einloggen, um Zugang zu erhalten
Excerpt
Vasovagal syncope (VVS) is the primary entity of neurally mediated syncope (NMS) in childhood, and its prognosis is usually considered benign. However, it is found in clinical practice that some children with VVS appear to have a frequent recurrence of syncope and poor response to treatment [
1], which might seriously affect their quality of life [
2]. In recent years, an increasing number of comorbidities of VVS have been reported. Liao et al. found that 31% of pediatric patients with NMS suffered from allergic disease [
3], and Vallejo M reported that more than 50% of patients had headaches [
4]. These comorbidities might make the clinical manifestations even more complex. However, until now, it has been unclear whether comorbidities are associated with the prognosis of children and adolescents suffering from VVS. Therefore, the present study was conducted to examine whether there is any impact of comorbidities on the prognosis of pediatric VVS to better understand the outcome and management of children and adolescents with VVS. …